✦ LIBER ✦

Guidelines for the treatment of Parkinson's disease remain unchanged

Book ID: 120864378
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 133 KB
Volume: 1321
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213210-00007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Workshop IV: Drug treatment guidelines f

Workshop IV: Drug treatment guidelines for the long-term management of Parkinson's disease

✍ H. Reichmann, U. Sommer, G. Fuchs, H. Hefter, G. Mark, T. Müller… 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 64 KB

Parkinson’s disease and hospitalization:

Parkinson’s disease and hospitalization: The need for guidelines

✍ Oliver H.H. Gerlach; Valerie J.H. Rouvroije; Wim E.J. Weber 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Parkinson's disease: What remains of the

Parkinson's disease: What remains of the “missing heritability”?

✍ Lasse Pihlstrøm; Mathias Toft 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

In recent years, the feasibility of performing large, genome-wide association studies (GWASs) has provided a powerful tool to identify susceptibility loci in complex diseases. GWASs utilize microarrays of several hundred thousand single-nucleotide polymorphisms (SNPs) to capture a significant amount

Istradefylline for the treatment of Park

Istradefylline for the treatment of Parkinson's disease

✍ Park, Ariane; Stacy, Mark 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 190 KB

Treatment for the progression of Parkins

Treatment for the progression of Parkinson's disease

✍ Donald Calne; Michael Schulzer; Edwin Mak; A Jon Stoessl 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 260 KB

Levodopa for the Treatment of Parkinson'

Levodopa for the Treatment of Parkinson's Disease

✍ LeWitt, Peter A. 📂 Article 📅 2008 🏛 Massachusetts Medical Society 🌐 English ⚖ 535 KB